“ Significantly, only individuals in the leronlimab-treated group who responded to the treatment showed an increase in CCR5 expression during the 8-week period. Such an increase in CCR5 expression was absent in non-responders.”

Did the non-responders have a normal level of CCR5 on their cell surfaces? I think it says that they also had less CCR5 on their cells and still didn’t respond the same as responders did. I wonder why.